Hepatitis B, Chronic - 29 Studies Found

No longer available : Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
: Hepatitis B, Chronic
: 2014-12-23
: Drug: Emtricitabine emtricitabine were given to each patients for 48 weeks
Completed : Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
: Hepatitis B, Chronic
: 2011-11-17
: Drug: GSK548470 300 mg tablet Blue tablets containing 300 mg of tenofovir disoproxil fumarate
Completed : Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B
: Hepatitis B, Chronic
: 2014-02-27
: Drug: Adefovir dipivoxil or Entecavir Adefovir tablet, 10m
Completed : Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
: Hepatitis B, Chronic
: 2009-06-15
:
  • Drug: Entecavir and peginterferon alfa-2a

Completed : Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
: Hepatitis B, Chronic
: 2009-06-08
:
  • Drug: Entecavir and peginterferon (Pegasys) (52 weeks)

Completed : Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
: Hepatitis B, Chronic
: 2011-03-08
: Drug: Peginterferon alfa-2a Peginterferon alfa-2a at 180 ug weekly for 24 weeks
Completed : Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
: Hepatitis B, Chronic
: 2006-11-01
: Drug: entecavir Tablets, Oral, 1 mg, once daily, up to 72 weeks
Completed : Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
: Hepatitis B, Chronic
: 2011-11-23
:
  • Drug: GSK548470 300 mg tablet

Not yet recruiting : Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
: Hepatitis B, Chronic
: 2014-12-23
: Drug: Emtricitabine emtricitabine were given to each patients at baseline and respoonse guided therapy w
Completed : Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B
: Hepatitis B, Chronic
: 2008-03-26
: Drug: Telbivudine 600 mg/day, oral telbivudine for 52 weeks
Next >>>